Create, analyze, optimize your ETF portfolio. Start now →
First Trust Nasdaq Pharmaceuticals ETF
FTXH performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 23, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +2.97% | +0.94% | +3.34% | +39.92% | +32.02% | +39.07% |
| Flows | +$2M | +$7M | +$9M | +$11M | -$7M | +$3M |
Characteristics
The First Trust Nasdaq Pharmaceuticals ETF is built to track the NASDAQ US Smart Pharmaceuticals Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | First Trust |
| N° of holdings | 50 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | September 20, 2016 |
| ESG | No |
More data and info about FTXH on Trackinsight
Exposure
Data as of March 31, 2026Diversification
Total weight of top 15 holdings out of 50
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +17.49% | +18.15% | +16.09% | +15.79% |
Max drawdown | -7.50% | -7.50% | -19.32% | -19.32% |
Max drawdown duration | 53d | 53d | 393d | 393d |
Time to recover | N/A | N/A | 174d | 174d |
Replication quality
Data as of March 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is FTXH?
FTXH is a Passive ETF that provides exposure to Equity assets. It is managed by First Trust.
What index does FTXH track?
FTXH tracks the NASDAQ US Smart Pharmaceuticals Total Return Index - USD, aiming to replicate its performance through optimized sampling.
What does FTXH invest in?
This ETF provides exposure to Other US Pharmaceuticals Equities. It is part of the segment: US Health Care.
What is the expense ratio of FTXH?
The total expense ratio (TER) of FTXH is 0.6%, representing the annual fee charged by the fund manager.
When was FTXH launched?
FTXH was launched on September 20, 2016, marking its entry into the ETF market.
Who is the issuer of FTXH?
FTXH is issued by First Trust.
What is the AUM of FTXH?
As of April 23, 2026, FTXH manages $30.57 M, reflecting the total assets held in the fund.
How has FTXH performed recently?
As of April 23, 2026, FTXH delivered a return of 2.97% over the past month (1M performance), 0.94% over the past three months (3M), and 3.34% year-to-date (YTD).
What are the recent fund flows for FTXH?
As of April 23, 2026, FTXH has seen net flows of +$2M in the past month (1M flow) and +$9M year-to-date (YTD).
Does FTXH pay dividends?
As of April 23, 2026, FTXH has a trailing 12-month distribution yield of 1.24%.
How many holdings are in FTXH
As of March 31, 2026, FTXH holds 50 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is FTXH?
As of March 31, 2026, FTXH holds 50 securities, with 71% of its assets concentrated in its top 15 holdings.
What are the top holdings of FTXH?
As of March 31, 2026, FTXH holds a portfolio of 50 underlyings, with its largest positions including BRISTOL-MYERS SQUIBB, JOHNSON&JOHNSON and MERCK & CO INC. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does FTXH invest in?
As of March 31, 2026, FTXH has its largest geographic exposures in USA.
What sectors or themes does FTXH focus on?
As of March 31, 2026, FTXH is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.